152 related articles for article (PubMed ID: 4365124)
1. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition.
Halliday WJ; Halliday JW; Campbell CB; Maluish AE; Powell LW
Br Med J; 1974 May; 2(5915):349-52. PubMed ID: 4365124
[TBL] [Abstract][Full Text] [Related]
2. [The existence of alpha 1-fetoprotein apart from hepatoma].
Andrieu J; Breart G; Rodier B; Robert PE
Presse Med (1893); 1971; 79(36):1595-6. PubMed ID: 4328551
[No Abstract] [Full Text] [Related]
3. Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):336-43. PubMed ID: 6092190
[TBL] [Abstract][Full Text] [Related]
4. Australia antigen and antibody and alpha-fetoglobulin in hepatoma patients.
Hersh T; Hollinger FB; Goyal RK; Grubb MN; Melnick JL
Int J Cancer; 1971 Sep; 8(2):259-63. PubMed ID: 4109107
[No Abstract] [Full Text] [Related]
5. Hepatocellular carcinoma: relation to alcohol, HB-antigen and alpha-fetoprotein.
Dourdourekas D; Villa F; Szanto PB; Steigmann F
Am J Gastroenterol; 1975 Apr; 63(4):307-11. PubMed ID: 48339
[TBL] [Abstract][Full Text] [Related]
6. [Carcino-fetal antigens in gastroenterology].
Chevrel B
Presse Med (1893); 1971; 79(36):1579. PubMed ID: 4328550
[No Abstract] [Full Text] [Related]
7. Primary liver cancer, alpha1 fetoprotein and hepatitis B antigen in Papua New Guinea.
Woodfield DG; Endo Y; Matsuhashi T
Aust N Z J Med; 1974 Feb; 4(1):3-7. PubMed ID: 4135927
[No Abstract] [Full Text] [Related]
8. Alpha-Fetoprotein and hepatitis B antigen in hepatoma and hepatitis.
Ichida F; Shibasaki K
Ann N Y Acad Sci; 1975 Aug; 259():259-60. PubMed ID: 54029
[No Abstract] [Full Text] [Related]
9. [Immunity and tumors. Immunologic diagnosis of onco-fetal antigenic tumors].
Dammacco F; Miglietta A
Recenti Prog Med; 1973 May; 54(5):396-403. PubMed ID: 4354411
[No Abstract] [Full Text] [Related]
10. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.
Halliday WJ; Maluish A; Isbister WH
Br J Cancer; 1974 Jan; 29(1):31-5. PubMed ID: 4820944
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.
Vogel CL; Anthony PP; Mody N; Barker LF
Lancet; 1970 Sep; 2(7674):621-4. PubMed ID: 4195767
[No Abstract] [Full Text] [Related]
12. Alpha-fetoprotein and Australia antigen in primary liver cancer.
Dammacco F; Miglietta A; Antonaci S; Bonomo L
Digestion; 1973; 9(1):41-8. PubMed ID: 4356403
[No Abstract] [Full Text] [Related]
13. Leucocyte adherence inhibition for detecting specific tumour immunity in early pancreatic cancer.
Tataryn DN; MacFarlane JK; Thomson DM
Lancet; 1978 May; 1(8072):1020-2. PubMed ID: 76938
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fetoprotein: its immunofluorescent localization in human fetal liver and hepatoma.
Purtilo DT; Yunis EJ
Lab Invest; 1971 Oct; 25(4):291-4. PubMed ID: 4107194
[No Abstract] [Full Text] [Related]
15. [Diagnostic value of carcino-fetal antigens in digestive tumors].
Martin F; Bourgeaux C; Martin MS
Arch Fr Mal App Dig; 1971 Mar; 60(3):95-102. PubMed ID: 4325274
[No Abstract] [Full Text] [Related]
16. Fetal antigens in human digestive tumors.
Martin F; Martin MS; Bourgeaux C
Eur J Cancer (1965); 1976 Mar; 12(3):165-75. PubMed ID: 59668
[No Abstract] [Full Text] [Related]
17. Relationship of hepatitis B antigen in cirrhosis and hepatoma in Thailand. An etiological significance.
Chanuvati T; Viranuvatti V; Pongpipat D
Gastroenterology; 1975 May; 68(5 Pt 1):1261-4. PubMed ID: 47828
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1-fetoprotein: serologic marker of human hepatoma and embryonal carcinoma.
Alpert E
Natl Cancer Inst Monogr; 1972 Dec; 35():415-20. PubMed ID: 4349153
[No Abstract] [Full Text] [Related]
19. The incidence and significance of Australia antigen in cancer patients.
al-Sarraf M; Kithier K; Sardesai S; Vaitkevicius VK; Poulik MD
Oncology; 1973; 27(2):128-36. PubMed ID: 4349676
[No Abstract] [Full Text] [Related]
20. Hepatitis associated antigen in various clinical conditions especially in primary hepatoma and metastatic liver cancer.
Wakui K; Ueno T; Kumata H; Suzuki H; Tokawa Y
Tohoku J Exp Med; 1974 Oct; 114(2):183-8. PubMed ID: 4373875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
